- Home
- LYEL vs FEIM Comparison
LYEL vs FEIM Comparison
Compare LYEL & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- FEIM
- Stock Information
- Founded
- LYEL 2018
- FEIM 1961
- Country
- LYEL United States
- FEIM United States
- Employees
- LYEL N/A
- FEIM N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- FEIM Electrical Products
- Sector
- LYEL Health Care
- FEIM Industrials
- Exchange
- LYEL Nasdaq
- FEIM Nasdaq
- Market Cap
- LYEL 207.7M
- FEIM 224.9M
- IPO Year
- LYEL 2021
- FEIM N/A
- Fundamental
- Price
- LYEL $10.30
- FEIM $22.32
- Analyst Decision
- LYEL Sell
- FEIM
- Analyst Count
- LYEL 2
- FEIM 0
- Target Price
- LYEL $15.00
- FEIM N/A
- AVG Volume (30 Days)
- LYEL 171.0K
- FEIM 328.1K
- Earning Date
- LYEL 08-06-2025
- FEIM 09-09-2025
- Dividend Yield
- LYEL N/A
- FEIM 4.43%
- EPS Growth
- LYEL N/A
- FEIM 604.98
- EPS
- LYEL N/A
- FEIM 2.41
- Revenue
- LYEL $65,000.00
- FEIM $65,400,999.00
- Revenue This Year
- LYEL N/A
- FEIM N/A
- Revenue Next Year
- LYEL N/A
- FEIM N/A
- P/E Ratio
- LYEL N/A
- FEIM $9.37
- Revenue Growth
- LYEL N/A
- FEIM 24.10
- 52 Week Low
- LYEL $7.65
- FEIM $8.83
- 52 Week High
- LYEL $38.40
- FEIM $24.77
- Technical
- Relative Strength Index (RSI)
- LYEL 49.76
- FEIM 57.16
- Support Level
- LYEL $9.11
- FEIM $20.42
- Resistance Level
- LYEL $9.84
- FEIM $21.49
- Average True Range (ATR)
- LYEL 0.63
- FEIM 1.41
- MACD
- LYEL -0.03
- FEIM -0.12
- Stochastic Oscillator
- LYEL 46.73
- FEIM 42.67
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.